That one arm of the phase III trial has gone from 75% enrolment at the start of August last year to fully enrolled now is a big + ve given the previous rate of enrolment. Looking at when this trial started there are now patients out there who have already been part of the trial for 2 years and so have already finished the 1 year follow up which makes me wonder where do these patients sit if they have had or maintained significant visual gains as a result of this trial.
That one arm of the phase III trial has gone from 75% enrolment...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
0.030(6.12%) |
Mkt cap ! $344.6M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 52.0¢ | 48.3¢ | $273.6K | 546.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 47051 | 50.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 16084 | 2 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
51.8¢ |
Change
0.030 ( 4.86 %) |
||||
| Open | High | Low | Volume | ||
| 48.5¢ | 52.0¢ | 48.5¢ | 102223 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| OPT (ASX) Chart |